参考文献/References:
[1] Bolton CF.Polyneuropathy in critically ill patients[J].J Neurol Neurosurg Psychiatry,2012,83(5):475.
[2] Stevens RD,Dowdy DW,Michaels RK,et al.Neuromuscular dysfunction acquired in critical illness:a systematic review[J].Intensive Care Med,2007,33(11):1876-1891.
[3] Witt NJ,Zochodne DW,Bolton CF,et al.Peripheral nerve function in sepsis and multiple organ failure[J].Chest,1991,99(1):176-184.
[4] Bercker S,Weber-Carstens S,Deja M,et al.Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome[J].Crit Care Med,2005,33(4):711-715.
[5] De Jonghe B,Sharshar T,Lefaucheur JP,et al.Paresis acquired in the intensive care unit: a prospective multicenter study[J].JAMA,2002,288(22):2859-2867.
[6] Van Den Berghe G,Wilmer A,Hermans G,et al.Intensive insulin therapy in the critically ill patients[J].N Engl J Med,2001,354(19):1359-1367.
[7] Khalil Y, El Din Mustafa E, Youssef A,et al. Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure[J]. Alexandria J Med,2012,48(3):223-232.
[8] De Jonghe B,Bastuji-Garin S,Sharshar T,et al.Dose ICU-acquired paresis lengthen weaning from mechanical ventilation? [J].Intensive Care Med,2004,30(6):1117-1121.
[9] Garnacho-Montero J,Amaya-Villar R,Garc a-Garmend a JL,et al.Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients[J].Crit Care Med,2005,33(2):349-354.
[10] Habib F.Respiratory failure after surgery or trauma.In:Stephen[C]//M,FL:Taylor&Francis Group,2006:271-286.
[11] Fink MP, Evans TW. Mechanisms of organ dysfunction in critical illness: report from a round table conference held in Brussels[J]. Intensive Care Med,2002,28(3):369-375.
[12] Waclawik AJ,Sufit RL,Beinlich BR,et al.Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium[J].Neuromuscul Disord,1992,2(1):19-26.
[13] Hund E.Neurological complications of sepsis:critical illness polyneuropathy and myopathy[J].J Neurol,2001,248(11):929-934.
[14] Latronico N,Bolton CF.Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis[J].Lancet Neurol,2011,10(10):931-941.
[15] Novak KR,Nardelli P,Cope TC,et al.Inactivation of Sodium channels underlies reversible neuropathy during critical illness in rats[J].Journal of Clinical Investigation,2009,119(5):1150-1158.
[16] Di Giovanni S,Mirabella M.D'amico a,tonali P,servidei S[J].Apoptotic feature accompany acute quadriplegic myopathy.Neurology,2000,55(6):854-858.
[17] Fenzi F,Latronico N,Refatti N,et al.Enhanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disease[J].Acta Neuropathol,2003,160(1):75-82.
[18] Latronisco N,Peli E,Botteri M.Critical illness myopathy and neuropathy[J].Curr Opin Crit Care,2005,11(2):126-132.
[19] Linos K,Foot C,Ziegenfuss M,et al.Critical illness weakness:common questions[J].Curr Anesth Crit Care,2007,18:252-260.
[20] Heunks LE.Van der hoeven JG[J].Critical review:the ABC of weaning failure-a structured approach.Crit Care,2010,14(6):245.
[21] Lacomis D,Zochodne DW,Bird SJ.Critical illness myopathy:what's in a Name?[J].Muscle Nerve,2000,23(12):1767-1772.
[22] Visser LH.Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis[J].European Journal of Neurology,2006,13(11):1203-1212.
[23] Lacomis D.Electrophysiology of neuromuscular disorders in critical illness[J].Muscle Nerve,2013,47(3):452-463.
[24] Bednarik J,Lukas Z,Vondracek P.Critical illness polyneuromyopathy: the electrophysiological components of a complex entity[J].Intensive Care Med,2003,29(9):1505-1514.
[25] Rich M,Pinter MJ.Crucial role of Sodium Channel fast inactivation in muscle fiber inexcitability in a rat model of critical illness myopathy[J].J Physiol,2003,547(pt 2):555-566.
[26] Trojaborg W,Weimer LH,Hays AP.Electrophysiologic studies in critical illness associated weakness: myopathy or neuropathy--a reappraisal[J].Clin Neurophysiol,2001,112(9):1586-1593.
[27] Allen DC,Arunachalam R,Mills KR.Critical illness myopathy:further evidence from muscle-fiber excitability studies of an acquired channelopathy[J].Muscle Nerve,2008,37(1):14-22.
[28] Zifko Ua ZH,Electrophysiological Findings in Critical Illness Polyneuropathy[J].J Neurol Sci,1998,159(2):186-193.
[29] Madams D,Soilemezmi E,Tsagourias M,et al.Sonographic evaluation of the diaphragm in critically ill patients[J].Technique and clinical applications.Intensive Care Med,2013,39(5):801-810.
[30] Raghig H,Young GB,Hammond R,et al.A comparison of EMG and muscle biopsy in ICU weakness[J].Neurocrit Care,2010,13(3):326-330.
[31] Amato AA,Russell JA.Myopathies associated with system disease.In:Neuromuscular[C]//Disorders,2008:721-736.
[32] Guarneri B,Bertolini G,Latronico N.Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study[J].J Neurol Neurosurg Psychiatry,2008,79(7):838-840.
[33] Dellinger RP,Levy MM,Rhodes A,et al.Surviving sepsis campaign guidelines committee including the pediatric subgroup[J].Surviving Sepsis Campaign:international guidelines formanagement of severe sepsis and septic shock.Intensive Care Med,2013,39(2):165-228.
[34] Intiso D,Amoruso L,Zarrelli M,et al.Long-term functional outcome and health status of patients with critical illness polyneuromyopathy[J].Acta Neorl Scand,2001,123(3):211-219.
[35] NICE-SUGAR Study Investigators,Finfer S,Chittock DR,et al.Intensive versus conventional glucose control in critically ill patients[J].N Engl J Med,2009,360(13):1283-1297.
[36] Brunner R,Rinner W,Haberler C,et al.Early treatment with IgM-enriched intravenous immunoglobulin dose not mitigate critical illness polyneuropathy and/or myopathy in patients with multi-organ failure and SIRRS/sepsis:a prospective,randomized,placebo-controlled,double-blinded trial[J].Crit Care,2013,17(5):R213.
[37] Hermans G.Van der berghe G[Z],2015:R274.
[38] Mehrholz J,Pohl M,Kugler J,et al.Physical rehabilitation for critical illness myopathy and neuropathy[J].Cochrane Database Syst Rev,2015,3:CD010942.
[39] Na.O'brien JM Jr,hoffman SP,et al; Midwest critical care consortium[J].Acquired weakness,handgrip strength and mortality in critically ill patients.Am J Respir Crit Care Med,2008,178(3):261-268.
[40] Nordon-Craft A,Schenkman M,Ridgeway K,et al.Physical therapy management and patient outcomes following ICU-acquired weakness: a case series[J].J Neurol Phys Ther,2011,35(3):133-140.
[41] Schweickert WD,Pohlman MC,Pohlman AS,et al.Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial[J].Lancet,2009,373(9678):1874-1882.
[42] Llano-Diez M,Renaud G,Andersson M,et al.Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading[J].Crit Care,2012,16(5):R209.
[43] Gerovasili V,Stefanidis K,Vitzilaios K,et al.Electrical muscle stimulation preserves the muscle mass of critically ill patients: a randomized study[J].Critical Care,2009,13(5):R161.
[44] Routsi C,Gerovasili V,Vasileiadis I,et al.Electrical muscle stimulation prevents critical illness polyneuromyopathy: a randomized parallel intervention trial[J].Crit Care,2010,14(2):R74.
[45] Hermans G,Casaer MP,Clerckx B,et al.Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial[J].Lancet Respir Med,2013,1(8):621-629.